Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 47 min ago

Oncology

5,778 studies502 in 7 days2,682 in 30 days

Filters
Type
Date
Clear

Latest

5,778 studies

  1. Enhanced Melan‐A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67
    Peter N. Kundert, Elsayed H. Ibrahim, Victor G. Prieto +1
    Journal of Cutaneous PathologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1
    Liubing Du, Mengxuan Wang, Xue Liu +13
    Acta pharmaceutica Sinica. BPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Heterogeneous and dynamic lung cancer mortality among immigrants relative to native-born populations in France, 2000–2021
    Patricia Macneil, Fanny Godet, Simon Ducarroz +1
    European Journal of Public HealthPeer-reviewedCC BY 4.0Full text1 citedOncologyHAL
  4. PD-L1 expression across molecular driver subsets in non-small cell lung carcinoma: a 299-case real-world thoracic oncology cohort.
    Arzu Taşdemir, Hatice Karaman, Nihal Kiremit +3
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. PRInter: an inductive multimodal heterogeneous network embedding framework with contrastive learning for lncRNA-protein interaction prediction
    Guoqing Zhao, Baolu Shi, Pengpai Li +1
    BMC BioinformaticsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  6. The clinical value of 68Ga-FAPI to evaluate the peritoneal fibrosis and its inherent molecule relationship with POSTN and DPP7
    Kaiying Xiao, Yuting Zhang, Hongpin Peng +7
    Journal of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  7. Impact of neuropathy severity on hand function, strength, and dexterity in patients with oxaliplatin-induced peripheral neuropathy.
    Özge Köseoğlu, Selvi Dinçer, Necla Gürdal +2
    BMC cancerPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  8. ESM1 drives H4K8 lactylation to promote vasculogenic mimicry and bevacizumab resistance in ovarian cancer
    Yukun Li, Juan Zou, Li Yang +7
    Cell Communication and Signaling : CCSPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  9. Upregulation of miR-200b-3p serves as a diagnostic biomarker for coronary atherosclerosis and regulates the oxidized low-density lipoprotein cholesterol-induced dysfunction of vascular smooth muscle cells
    Yuxuan Xia, Yujuan Gao, Fei Chai +2
    BMC Cardiovascular DisordersPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  10. Early-onset colorectal cancer in Korea: clinical characteristics, treatment patterns, and survival outcomes in a K-CURE nationwide population-based study
    Kyunghye Bang, Dawoon Jeong, Semie Hong +4
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  11. SLC10A1 variants causing NTCP deficiency in infants: clinical and functional characterization of a novel splice-site variant
    Wenzhuo Cheng, Fan Chen, Wen Pan +2
    BMC PediatricsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  12. Development and internal validation of a risk stratification model for high-intensity psychosocial service use among women living with and beyond breast cancer
    Limor Dina Gonen, Sharon Barak, Riki Tesler +1
    BMC Women's HealthPeer-reviewedCC BY 4.0Full textOncologyPMC
  13. P4HA2 mediates hypoxia-induced collagen remodeling to promote tumor progression in head and neck squamous cell carcinoma
    Chaochao Zhang, Ruihuan Gan, Limei Wang +5
    Cellular OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  14. Managing chemobrain: Translational insights and evidence-based psychological interventions
    Tamás Szekeres, Márta Virág, Magdolna Dank +1
    CNS SpectrumsPeer-reviewedCC BY 4.0Full textOncologyPMC
  15. Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours
    Samuel O. H. Ching, Anderson S. M. Leung, Raymond C. H. Yau +3
    Journal of Surgical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases
    Kaijie Zhou, Licheng Zhou, Jean C. Tien +23
    Acta pharmaceutica Sinica. BPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  17. Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL
    Stephan A. Grupp, Shannon L. Maude, Susana Rives +26
    Journal of Clinical OncologyPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  18. FGD5-AS1 downregulates miR-129-5p levels to promote cardiomyocyte injury and apoptosis, accelerating the progression of chronic heart failure
    Rongwen Lin, Jinhe Chen, Zhiying He +1
    Journal of Cardiothoracic SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  19. Cholesterol metabolism reprogramming: shaping tumor immunity and immunotherapy
    Jing-Wen Meng, Yue-Tao Tan, Shan-Mei Chen +2
    Journal of Experimental & Clinical Cancer Research : CRPeer-reviewedCC BY 4.0Full textOncologyPMC
  20. Microfluidic platforms for CAR-T cell engineering: a multidisciplinary review on potential next generation intracellular delivery method
    Isabela Aparecida de Araujo Andreotti, Gabriel Griep, Edgar Andrés Patiño Nariño +4
    Journal of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  21. A comparison of extended right hemicolectomy and transverse colectomy with D3 lymph node dissection for pathological stage II/III advanced mid-transverse colon cancer
    Emi Ota, Mayumi Ozawa, Kazuya Nakagawa +3
    International Journal of Colorectal DiseasePeer-reviewedCC BY 4.0Full textOncologyPMC
  22. Description of three new types of aurantiactinomyxon actinospores (Myxozoa: Myxosporea) from the oligochaete Aulophorus sp. in Tasik Telabak, Malaysia
    Nadhirah Syafiqah Suhaimi, Csaba Székely, Gábor Cech +2
    Parasitology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Plasmablastic non-Hodgkin's lymphoma: a case report and review of the literature.
    Imran Saleem Solanki, Rajanikanth Kambala, Nitin Bhola +1
    Journal of medical case reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  24. A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study.
    Sirui Zhang, Lingyun Xu, Wenting Peng
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  25. Characterisation of a novel p53 mutation (p53N263Tfs*7) associated with li-fraumeni syndrome.
    Francesca M Wright, Mariela Vasileva-Slaveva, Angel Yordanov +6
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMC